Episurf Medical AB OMXSTO:EPIS_B:
EPISURF'S IMPLANTS MARKET APPROVED IN SINGAPORE
Episurf's Implants Market Approved In Singapore
Earlier from Episurf Medical
- EPIS_B: US growth and cost savings drive improved results, but financing uncertainty persists
- Episurf Medical AB: Quarterly Trading Report 2025 Q3
- EPIS_B: Adjusted EBIT improved, U.S. order intake surged, and a SEK 29.4m rights issue is planned
- EPIS_B: Record Q1 sales and US growth position Episurf for accelerated expansion and improved results
- EPIS_B: Net sales grew, losses narrowed, and US market expansion accelerated, supported by new funding
Later from Episurf Medical
- Episurf Acquires Real Estate Assets, Forms New Business Segment
- Episurf Acquires Properties From Klarabo
- EPIS_B: Operating losses narrowed as sales grew and real estate investments began, but financing risks remain
- Jens Andersson Appointed As CEO Of Episurf
- Episurf Medical To Issue Class B Shares, Debentures
Follow Episurf Medical into a list and get an email when it puts out news.
Follow Episurf Medical